[1]
A. Fanous, A. Cheng, E. Ames, P. Harrah, and D. Schaefer, “Eruptive Disseminated Porokeratosis (EDP) Following Interleukin-6 Inhibitor Biologic (Actrema®) and Corticosteroid Induced Immunosuppression”, Journal of Clinical Dermatology and Surgery, vol. 2, no. 2, Sep. 2024, doi: 10.61853/z2nje517.